Recto-Anal-Repair in the Treatment of Advanced Haemorrhoidal Disease

Prospective observational study to evaluate the impact of Recto-Anal-Repair (a technique of ultrasound guided haemorrhoidal ligation) in the treatment of stage III/IV haemorrhoidal disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Haemorrhoids Cardiovascular Diseases Digestive System Diseases Gastrointestinal Diseases Hemorrhoids Intestinal Diseases Rectal Diseases Vascular Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Dept. of Surgery, Medical University Vienna

Vienna, State of Vienna, 1090, Austria

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Stage III or IV hemorrhoidal disease (Appendix A)
Patient age 18-80 years old
Patient fit for general or local anesthesia
No prior surgical treatment for hemorrhoidal disease
No prior surgical treatment for anorectal sepsis
Signed informed consent

Exclusion criteria

Stage I or II hemorrhoidal disease (Appendix A)
Patient unfit for surgery
Clotting disorders
Anal or colorectal malignancy
Secondary hemorrhoidal disease
Pregnancy
Unwilling or unable to sign informed consent

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

Prospective Observational Study of Recto-Anal-Repair in the Treatment Haemorrhoidal Disease Stage III/IV

Important dates

Study start: 2007
Primary completion: 2007
Study completion: 2007
First posted: Feb 23, 2011
Registry last updated: Feb 23, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed